Valuation: Ipca Laboratories Limited

Market Cap 454B 4.76B 4.16B 3.84B 3.54B 6.72B 6.84B 45.85B 18B 223B 17.86B 17.47B 768B P/E 2026
35.6x
P/E 2027 * 32.2x
Enterprise Value 449B 4.7B 4.11B 3.79B 3.5B 6.65B 6.76B 45.34B 17.81B 221B 17.66B 17.28B 760B EV / Sales 2026
4.24x
EV / Sales 2027 * 4.1x
Free-Float
54.92%
Yield 2026
0.37%
Yield 2027 * 0.33%
1 day+0.99%
1 week+3.98%
Current month+5.11%
1 month+9.42%
3 months+23.31%
6 months+13.52%
Current year+26.01%
1 week 1,741
Extreme 1741
1,812.5
1 month 1,530
Extreme 1530
1,812.5
Current year 1,391.8
Extreme 1391.8
1,812.5
1 year 1,251.6
Extreme 1251.6
1,812.5
3 years 752.6
Extreme 752.6
1,812.5
5 years 669.8
Extreme 669.8
1,812.5
10 years 200
Extreme 200
1,812.5
Manager TitleAgeSince
Chief Executive Officer 53 01/04/2023
Chief Executive Officer 70 01/04/2023
Chief Tech/Sci/R&D Officer 52 16/10/2023
Director TitleAgeSince
Chairman 79 05/07/2012
Director/Board Member 53 11/11/2008
Director/Board Member 70 01/08/1994
Date Insider Type Main position Quantity % Market Cap.
19/12/24Sell 4,000,000 1.5766%
Change 5-day change 1-year change 3-year change Capi.($)
+0.99%+3.98%+22.84%+135.47% 4.71B
-2.60%-0.93%+50.36%+162.35% 1,085B
-1.15%-1.12%+62.61%+60.75% 624B
-1.52%-3.25%+26.40%+83.27% 442B
+0.33%-1.17%+27.98%+26.90% 332B
-3.89%-11.22%+20.78%+26.07% 277B
-0.02%-2.85%+25.27%+44.88% 282B
+0.66%-1.42%-29.26%-39.30% 217B
-0.09%-0.73%+21.10%+61.86% 196B
-3.70%+0.44%+13.66%+72.00% 167B
Average -1.17%-1.38%+24.17%+63.42% 362.66B
Weighted average by Cap. -1.63%-1.05%+35.22%+81.61%

Financials

2026 2027 *
Net sales 96.62B 1.01B 886M 817M 755M 1.43B 1.46B 9.77B 3.83B 47.6B 3.8B 3.72B 164B 108B 1.13B 988M 911M 841M 1.6B 1.62B 10.88B 4.27B 53.05B 4.24B 4.15B 182B
Net income 11.21B 118M 103M 94.81M 87.56M 166M 169M 1.13B 445M 5.52B 441M 432M 18.98B 14B 147M 128M 118M 109M 208M 211M 1.42B 556M 6.9B 551M 539M 23.71B
Net Debt -5.02B -52.6M -46.01M -42.44M -39.2M -74.38M -75.63M -507M -199M -2.47B -198M -193M -8.5B -11.82B -124M -108M -100M -92.38M -175M -178M -1.2B -469M -5.82B -465M -455M -20.02B
Logo Ipca Laboratories Limited
Ipca Laboratories Limited is an India-based integrated pharmaceutical company. The Company is engaged in manufacturing and marketing over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) covering various therapeutic segments. It offers APIs, such as Atenolol, Chloroquine Phosphate, Chlorthalidone, Furosemide, Hydroxychloroquine sulfate, Losartan, Metoprolol Succinate, Metoprolol Tartrate, Pyrantel Salts and Propranolol. The Company offers brands, such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, Venpower and Folitrax. The Company’s products are sold in over 100 countries across the globe. The Company has 18 manufacturing units in India manufacturing APIs and formulations. Its subsidiaries include Ipca Pharmaceuticals, Inc. and Ipca Pharma Nigeria Ltd.
Employees
16,778
Date Price Change Volume
10/07/26 1,787.90 +0.99% 146,840
09/07/26 ₹1,770.40 +0.45% 96,723
08/07/26 ₹1,762.40 -1.71% 166,406
07/07/26 ₹1,793.10 +0.60% 139,839
06/07/26 ₹1,782.40 +0.20% 393,648
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
1,787.90INR
Average target price
1,733.50INR
Spread / Average Target
-3.04%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IPCALAB Stock